Shares of Alere (NYSE: ALR), a provider of diagnostic tests to the medical community for disease detection, plunged as much as 16% during Friday's trading session after releasing disappointing ...

Alere's Apollo technology, a fully integrated health management solution connecting providers, payers and patients, combined with Business Process Management (BPM) technology from Pegasystems, will ...

, an Alere subsidiary specializing in analytics and clinical decision support (CDS) technology, today announced the launch of its Clinical Surveillance product for hospitals, which is an automated ...

Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere Inc at a lower price than it had ...

Federal criminal investigators have opened a new front in a probe of diagnostic testing company Alere, according to a new report that comes as the firm continues trying to sell itself to in a ...

Waltham, Mass.-based Alere, a medical diagnostics products company, is defending allegations from CMS that its subsidiary, which specializes in providing diabetic testing supplies to customers by mail ...

North suburban-based Abbott Laboratories is making up with Alere after nearly a year of fighting, agreeing to buy the Massachusetts-based company for a lower price and ending its legal battles over ...

What: Shares of Alere (NYSE: ALR), a pioneer of quick, point-of-care diagnostics, sank by 22.9% in April, according to data from S&P Global Market Intelligence. All it took was an off-the-cuff comment ...

Shares in Waltham, Mass.-based Alere rose after the company publically agreed to hand over documents disclosing its foreign operations and U.S. billing practices to Abbot Park, Ill.-based Abbott ...

Alere Inc. was promised quick treatment by a Delaware judge set to hear its complaint that Abbott Laboratories is stalling to avoid going through a $5.8 billion purchase of the medical diagnostic ...